GlassScriptPhysician profile
Megan M Sis
NPI 1013242197
$6,416.56
in general payments reported to CMS, 2019-2025
8 companies · $91.65 in 2025
The $91.65 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $435 · 2021: $14.76 · 2022: $1,927 · 2023: $2,836 · 2024: $1,112 · 2025: $91.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,242 · Food and Beverage: $797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,242.32 |
| Food and Beverage | $797.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $5,587.61 | 2019-2025 | Misight Contact Lens, Clariti Contact Lens |
| Optos, INC. | $237.31 | 2019 | |
| Glaukos Corporation | $197.98 | 2023 | Gts100-Glaukos Istent Trabecular Micro-Bypass Stent System, Istent Trabecular Micro-Bypass Stent System |
| Alcon Vision LLC | $171.65 | 2019-2025 | Precision 1, Precision7 |
| Johnson & Johnson Vision Care, INC. | $128.06 | 2019-2025 | |
| Rxsight INC | $66.44 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Allergan, INC. | $14.76 | 2021 | |
| Novartis Pharmaceuticals Corporation | $12.75 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Sis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.